Literature DB >> 25844913

Factors affecting implementation of an evidence-based practice in the Veterans Health Administration: Illness management and recovery.

Alan B McGuire1, Michelle P Salyers2, Dominique A White3, Daniel J Gilbride4, Laura M White2, Jacob Kean5, Marina Kukla6.   

Abstract

OBJECTIVE: Illness management and recovery (IMR) is an evidence-based practice that assists consumers in managing their illnesses and pursuing personal recovery goals. Although research has examined factors affecting IMR implementation facilitated by multifaceted, active roll-outs, the current study attempted to elucidate factors affecting IMR implementation outside the context of a research-driven implementation.
METHODS: Semi-structured interviews with 20 local recovery coordinators and 18 local IMR experts were conducted at 23 VA medical centers. Interviews examined perceived and experienced barriers and facilitators to IMR implementation. Data were analyzed via thematic inductive/deductive analysis in the form of crystallization/immersion.
RESULTS: Six factors differed between sites implementing IMR from those not providing IMR: awareness of IMR, importer-champions, autonomy-supporting leadership, veteran-centered care, presence of a sensitive period, and presence of a psychosocial rehabilitation and recovery center. Four factors were common in both groups: recovery orientation, evidence-based practices orientation, perceived IMR fit within program structure, and availability of staff time. CONCLUSIONS AND IMPLICATIONS FOR PRACTICE: IMR can be adopted in lieu of active implementation support; however, knowledge dissemination appears to be key. Future research should examine factors affecting the quality of implementation. (c) 2015 APA, all rights reserved).

Entities:  

Mesh:

Year:  2015        PMID: 25844913     DOI: 10.1037/prj0000116

Source DB:  PubMed          Journal:  Psychiatr Rehabil J        ISSN: 1095-158X


  6 in total

1.  Implementation and fidelity assessment of the NAVIGATE treatment program for first episode psychosis in a multi-site study.

Authors:  Kim T Mueser; Piper S Meyer-Kalos; Shirley M Glynn; David W Lynde; Delbert G Robinson; Susan Gingerich; David L Penn; Corrine Cather; Jennifer D Gottlieb; Patricia Marcy; Jennifer L Wiseman; Sheena Potretzke; Mary F Brunette; Nina R Schooler; Jean Addington; Robert A Rosenheck; Sue E Estroff; John M Kane
Journal:  Schizophr Res       Date:  2018-08-20       Impact factor: 4.939

2.  Using implementation facilitation to foster clinical practice quality and adherence to evidence in challenged settings: a qualitative study.

Authors:  Mona J Ritchie; Louise E Parker; Carrie N Edlund; JoAnn E Kirchner
Journal:  BMC Health Serv Res       Date:  2017-04-20       Impact factor: 2.655

3.  How to implement Illness Management and Recovery (IMR) in mental health service settings: evaluation of the implementation strategy.

Authors:  Karina Myhren Egeland; Torleif Ruud; Terje Ogden; Rickard Färdig; Jonas Christoffer Lindstrøm; Kristin Sverdvik Heiervang
Journal:  Int J Ment Health Syst       Date:  2017-01-23

4.  Significance of Leaders for Sustained Use of Evidence-Based Practices: A Qualitative Focus-Group Study with Mental Health Practitioners.

Authors:  Karina M Egeland; Mona-Iren Hauge; Torleif Ruud; Terje Ogden; Kristin Sverdvik Heiervang
Journal:  Community Ment Health J       Date:  2019-06-12

5.  Psychometric Properties of the General Organizational Index (GOI): A Measure of Individualization and Quality Improvement to Complement Program Fidelity.

Authors:  Kristin Sverdvik Heiervang; Karina Myhren Egeland; Matthew Landers; Torleif Ruud; Inge Joa; Robert E Drake; Gary R Bond
Journal:  Adm Policy Ment Health       Date:  2020-11

6.  Skills-based intervention to enhance collaborative decision-making: systematic adaptation and open trial protocol for veterans with psychosis.

Authors:  Amy N Cohen; Gregory A Light; Emily B H Treichler; Borsika A Rabin; William D Spaulding; Michael L Thomas; Michelle P Salyers; Eric L Granholm
Journal:  Pilot Feasibility Stud       Date:  2021-03-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.